China Supplier Fujimycin - Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality – Ruifu
China Supplier Fujimycin - Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Favipiravir (CAS: 259793-96-9) and Related Intermediates:
Favipiravir CAS: 259793-96-9
3,6-Dichloropyrazine-2-Carbonitrile CAS: 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS: 356783-28-3
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS: 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS: 55321-99-8
2-Aminopropanediamide CAS: 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS: 13433-00-6
Chemical Name | Favipiravir |
Synonyms | T-705; 6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide |
CAS Number | 259793-96-9 |
CAT Number | RF-API18 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C5H4FN3O2 |
Molecular Weight | 157.1 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Off-White Powder |
Identification | 1) IR 2) HPLC |
Melting Point | 188.0℃-193.0℃ |
Related Substances (Area Normalization) |
Any Single Impurity: ≤0.10% (HPLC) |
Total Impurities: ≤1.0% (HPLC) | |
Purity / Analysis Method | ≥99.0% (HPLC) |
Moisture (K.F) | ≤0.50% |
Residue on Ignition | ≤0.10% |
Heavy Metals | ≤20ppm |
Residue Solvents | |
Methanol | ≤3000ppm |
Ethyl Acetate | ≤5000ppm |
Isopropanol | ≤5000ppm |
Acetonitrile | ≤410ppm |
n-Heptane | ≤5000ppm |
Test Standard | Enterprise Standard |
Usage | Active Pharmaceutical Ingredient (API); Treatment of COVID-19 |
Package: Bottle, Aluminum foil bag, 25kg/Cardboard drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Favipiravir (T-705) (CAS 259793-96-9) is one of the 5 compounds recommended by WHO for the investigation of treatment of COVID-19.
Favipiravir (T-705) is a selective inhibitor of viral RNA-dependent RNA polymerase with activity against many RNA viruses, influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Favipiravir is a broad-spectrum antiviral drug that was cleared by the Drugs Controller General of India (DCGI) last week for “emergency restricted” use among Covid-19 patients. Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.
Product detail pictures:
Related Product Guide:
We attempt for excellence, provider the customers", hopes to be the most beneficial cooperation team and dominator enterprise for staff, suppliers and shoppers, realizes value share and continuous advertising for China Supplier Fujimycin - Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality – Ruifu , The product will supply to all over the world, such as: Uruguay, Philadelphia, Brazil, Our company always concentrate on the development of the international market. We have a lot of customers in Russia , European countries, the USA, the Middle East countries and Africa countries. We always follow that quality is foundation while service is guarantee to meet all customers.
By Chris Fountas from Curacao - 2017.01.11 17:15
It is not easy to find such a professional and responsible provider in today's time. Hope that we can maintain long-term cooperation.
By Rae from Tunisia - 2018.06.18 17:25